Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
WALTHAM, Mass. May 23, 2024 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the American Society of Clinical Oncology Annual Meeting next month demonstrating the first significant improvement in the early detection of ovarian cancer using a locked assay since CA125 serum biomarker testing and transvaginal ultrasound imaging were introduced nearly 40 years ago. In a large blinded, retrospective analysis of prospectively collected samples from more than 1,300 asymptomatic postmenopausal women, the Mercy Halo™ test detected 82% of high grade serous ovarian cancer (HGSC) cases up to one year prior to diagnosis with 98% specificity. Mercy, in collaboration with the team at the Medical Research Council Clinical Trials Unit (MRC CTU) at University College London (UCL), analyzed samples from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) in which over 200,000 women wer
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at BTIG Research from $80.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- Exact Sciences: Still No Reason To Own [Seeking Alpha]Seeking Alpha
- Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Exact Sciences (NASDAQ:EXAS) shareholders have endured a 63% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- UltraSight and Mayo Clinic join forces for AI-driven cardiac care [Yahoo! Finance]Yahoo! Finance
EXAS
Earnings
- 5/8/24 - Miss
EXAS
Sec Filings
- 6/25/24 - Form 11-K
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- EXAS's page on the SEC website